Michelle Fay Cortez and Matthew Monks of Bloomberg News report that Becton, Dickinson (BD) will be acquiring CareFusion in a $12.2 billion deal that is expected to reduce overhead expenses and result in greater cost savings and convenience to hospitals and as ASCs.
BD currently sells laboratory equipment, diagnostic tests and various drug delivery systems such as syringes and hypodermic needles. CareFusion is a leading provider of infusion pumps and drug dispensing systems. The merger of these two companies is expected to result in $250 million in cost savings by 2018. These savings should result in lower costs for customers who rely on these services.
Dan O’Connor of Outpatient Magazine reports that “the combination of the 2 companies' complementary product portfolios will offer integrated medication management solutions and smart devices, from drug preparation in the pharmacy, to dispensing on the hospital floor, administration to the patient and subsequent monitoring.”
Learn more about the merger by reading the full Bloomberg article here.
Did you know some patients say that dealing with post-op nausea and vomiting (PONV) is even more uncomfortable for them than managing post-op pain? Here are 5 smart steps Outpatient Surgery magazine suggests your ASC can take to help prevent PONV from causing your patients serious discomfort following surgery.
Doctors in Dayton, Ohio believe they may have found a minimally invasive alternative to gastric bypass surgery for the millions of Americans who are morbidly obese. Physicians at Dayton Interventional Radiology recently performed the first gastric artery embolization procedure as part of their GET LEAN (Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically) study. According to Outpatient Surgery Magazine, gastric artery embolization is a procedure that uses a small catheter to inject particles tinier than a grain of sand into the left gastric artery to block blood flow to the tiny branches of the artery. The catheter may be introduced into the groin or wrist and directed to the left gastric artery that supplies blood to the upper stomach. The goal of this embolization is to decrease the levels of the hormone ghrelin, which is responsible for appetite. While GET LEAN is the first human study on gastric artery embolization in the United States, a 2013 study on the procedure was conducted in the former Soviet Union on five patients who lost an average of 45 pounds in six months. Researchers at Johns Hopkins University and Duke University have also studied the procedure on animals and found significant weight loss and hormone suppression. Read the full story to learn more about this experimental procedure.
New research published in the Journal of Clinical Investigation suggests that anesthesia causes long-term memory loss in patients. Beverly Orser, MD, PhD, FRCPC, an instructor of anesthesiology and physiology at the University of Toronto, conducted the study on lab mice. The mice received Etomidate 8 mg/kg for 20 minutes and showed increased activity in their memory loss receptors for a week. The potential impact to patients, according to Orser, could last anywhere from days to months after surgery when patients need to remember post-op care instructions. In a recent article in Outpatient Surgery Magazine, Orser says the findings of her study are particularly important for high-risk patients who may need additional education and support to recover from the potential impact of post-op memory loss. In her study, Orser says “postoperative cognitive deficits are present in approximately 37% of young adults and 41% of elderly patients at hospital discharge and in 6% of young adults and 13% of elderly patients at 3 months after surgery. These deficits are associated with poor patient outcomes, including reduced quality of life, loss of independence, and increased mortality.” Learn more by reading the full study.
